The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antivirals-Global Market Insights and Sales Trends 2025
Synopsis
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
The global Antivirals market size is expected to reach US$ 62600 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Antivirals in various end use industries. The expanding demands from the HIV, Hepatitis, HSV and Influenza, are propelling Antivirals market. Generic, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Branded segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antivirals, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antivirals market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antivirals market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antivirals sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antivirals covered in this report include Merck, Johnson & Johnson, Teva Pharmaceutical Industries, GSK, Mylan, Gilead Sciences, F. Hoffmann-La Roche, Bristol-Myers-Squibb and AbbVie, etc.
The global Antivirals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Johnson & Johnson
Teva Pharmaceutical Industries
GSK
Mylan
Gilead Sciences
F. Hoffmann-La Roche
Bristol-Myers-Squibb
AbbVie
Aurobindo Pharma
Cipla
Dr Reddy’s
Global Antivirals market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antivirals market, Segment by Type:
Generic
Branded
Global Antivirals market, by Application
HIV
Hepatitis
HSV
Influenza
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antivirals manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antivirals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
The global Antivirals market size is expected to reach US$ 62600 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Antivirals in various end use industries. The expanding demands from the HIV, Hepatitis, HSV and Influenza, are propelling Antivirals market. Generic, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Branded segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antivirals, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antivirals market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antivirals market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antivirals sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antivirals covered in this report include Merck, Johnson & Johnson, Teva Pharmaceutical Industries, GSK, Mylan, Gilead Sciences, F. Hoffmann-La Roche, Bristol-Myers-Squibb and AbbVie, etc.
The global Antivirals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Johnson & Johnson
Teva Pharmaceutical Industries
GSK
Mylan
Gilead Sciences
F. Hoffmann-La Roche
Bristol-Myers-Squibb
AbbVie
Aurobindo Pharma
Cipla
Dr Reddy’s
Global Antivirals market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antivirals market, Segment by Type:
Generic
Branded
Global Antivirals market, by Application
HIV
Hepatitis
HSV
Influenza
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antivirals manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antivirals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Antivirals Market Overview
1.1 Antivirals Product Overview
1.2 Antivirals Market Segment by Type
1.2.1 Generic
1.2.2 Branded
1.3 Global Antivirals Market Size by Type
1.3.1 Global Antivirals Market Size Overview by Type (2018-2029)
1.3.2 Global Antivirals Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antivirals Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antivirals Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antivirals Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antivirals Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antivirals Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antivirals Sales Breakdown by Type (2018-2023)
2 Global Antivirals Market Competition by Company
2.1 Global Top Players by Antivirals Sales (2018-2023)
2.2 Global Top Players by Antivirals Revenue (2018-2023)
2.3 Global Top Players by Antivirals Price (2018-2023)
2.4 Global Top Manufacturers Antivirals Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antivirals Market Competitive Situation and Trends
2.5.1 Antivirals Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antivirals Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antivirals as of 2022)
2.7 Date of Key Manufacturers Enter into Antivirals Market
2.8 Key Manufacturers Antivirals Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antivirals Status and Outlook by Region
3.1 Global Antivirals Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antivirals Historic Market Size by Region
3.2.1 Global Antivirals Sales in Volume by Region (2018-2023)
3.2.2 Global Antivirals Sales in Value by Region (2018-2023)
3.2.3 Global Antivirals Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antivirals Forecasted Market Size by Region
3.3.1 Global Antivirals Sales in Volume by Region (2024-2029)
3.3.2 Global Antivirals Sales in Value by Region (2024-2029)
3.3.3 Global Antivirals Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antivirals by Application
4.1 Antivirals Market Segment by Application
4.1.1 HIV
4.1.2 Hepatitis
4.1.3 HSV
4.1.4 Influenza
4.2 Global Antivirals Market Size by Application
4.2.1 Global Antivirals Market Size Overview by Application (2018-2029)
4.2.2 Global Antivirals Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antivirals Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antivirals Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antivirals Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antivirals Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antivirals Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antivirals Sales Breakdown by Application (2018-2023)
5 North America Antivirals by Country
5.1 North America Antivirals Historic Market Size by Country
5.1.1 North America Antivirals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antivirals Sales in Volume by Country (2018-2023)
5.1.3 North America Antivirals Sales in Value by Country (2018-2023)
5.2 North America Antivirals Forecasted Market Size by Country
5.2.1 North America Antivirals Sales in Volume by Country (2024-2029)
5.2.2 North America Antivirals Sales in Value by Country (2024-2029)
6 Europe Antivirals by Country
6.1 Europe Antivirals Historic Market Size by Country
6.1.1 Europe Antivirals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antivirals Sales in Volume by Country (2018-2023)
6.1.3 Europe Antivirals Sales in Value by Country (2018-2023)
6.2 Europe Antivirals Forecasted Market Size by Country
6.2.1 Europe Antivirals Sales in Volume by Country (2024-2029)
6.2.2 Europe Antivirals Sales in Value by Country (2024-2029)
7 Asia-Pacific Antivirals by Region
7.1 Asia-Pacific Antivirals Historic Market Size by Region
7.1.1 Asia-Pacific Antivirals Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antivirals Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antivirals Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antivirals Forecasted Market Size by Region
7.2.1 Asia-Pacific Antivirals Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antivirals Sales in Value by Region (2024-2029)
8 Latin America Antivirals by Country
8.1 Latin America Antivirals Historic Market Size by Country
8.1.1 Latin America Antivirals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antivirals Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antivirals Sales in Value by Country (2018-2023)
8.2 Latin America Antivirals Forecasted Market Size by Country
8.2.1 Latin America Antivirals Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antivirals Sales in Value by Country (2024-2029)
9 Middle East and Africa Antivirals by Country
9.1 Middle East and Africa Antivirals Historic Market Size by Country
9.1.1 Middle East and Africa Antivirals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antivirals Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antivirals Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antivirals Forecasted Market Size by Country
9.2.1 Middle East and Africa Antivirals Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antivirals Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Antivirals Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Antivirals Products Offered
10.1.5 Merck Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson Antivirals Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Johnson & Johnson Antivirals Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Teva Pharmaceutical Industries
10.3.1 Teva Pharmaceutical Industries Company Information
10.3.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.3.3 Teva Pharmaceutical Industries Antivirals Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Teva Pharmaceutical Industries Antivirals Products Offered
10.3.5 Teva Pharmaceutical Industries Recent Development
10.4 GSK
10.4.1 GSK Company Information
10.4.2 GSK Introduction and Business Overview
10.4.3 GSK Antivirals Sales, Revenue and Gross Margin (2018-2023)
10.4.4 GSK Antivirals Products Offered
10.4.5 GSK Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Antivirals Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mylan Antivirals Products Offered
10.5.5 Mylan Recent Development
10.6 Gilead Sciences
10.6.1 Gilead Sciences Company Information
10.6.2 Gilead Sciences Introduction and Business Overview
10.6.3 Gilead Sciences Antivirals Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Gilead Sciences Antivirals Products Offered
10.6.5 Gilead Sciences Recent Development
10.7 F. Hoffmann-La Roche
10.7.1 F. Hoffmann-La Roche Company Information
10.7.2 F. Hoffmann-La Roche Introduction and Business Overview
10.7.3 F. Hoffmann-La Roche Antivirals Sales, Revenue and Gross Margin (2018-2023)
10.7.4 F. Hoffmann-La Roche Antivirals Products Offered
10.7.5 F. Hoffmann-La Roche Recent Development
10.8 Bristol-Myers-Squibb
10.8.1 Bristol-Myers-Squibb Company Information
10.8.2 Bristol-Myers-Squibb Introduction and Business Overview
10.8.3 Bristol-Myers-Squibb Antivirals Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bristol-Myers-Squibb Antivirals Products Offered
10.8.5 Bristol-Myers-Squibb Recent Development
10.9 AbbVie
10.9.1 AbbVie Company Information
10.9.2 AbbVie Introduction and Business Overview
10.9.3 AbbVie Antivirals Sales, Revenue and Gross Margin (2018-2023)
10.9.4 AbbVie Antivirals Products Offered
10.9.5 AbbVie Recent Development
10.10 Aurobindo Pharma
10.10.1 Aurobindo Pharma Company Information
10.10.2 Aurobindo Pharma Introduction and Business Overview
10.10.3 Aurobindo Pharma Antivirals Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Aurobindo Pharma Antivirals Products Offered
10.10.5 Aurobindo Pharma Recent Development
10.11 Cipla
10.11.1 Cipla Company Information
10.11.2 Cipla Introduction and Business Overview
10.11.3 Cipla Antivirals Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Cipla Antivirals Products Offered
10.11.5 Cipla Recent Development
10.12 Dr Reddy’s
10.12.1 Dr Reddy’s Company Information
10.12.2 Dr Reddy’s Introduction and Business Overview
10.12.3 Dr Reddy’s Antivirals Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Dr Reddy’s Antivirals Products Offered
10.12.5 Dr Reddy’s Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antivirals Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antivirals Industrial Chain Analysis
11.4 Antivirals Market Dynamics
11.4.1 Antivirals Industry Trends
11.4.2 Antivirals Market Drivers
11.4.3 Antivirals Market Challenges
11.4.4 Antivirals Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antivirals Distributors
12.3 Antivirals Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
